PPA
SQZ

Parametric Portfolio Associates’s SQZ Biotechnologies Company SQZ Stock Holding History

Parametric Portfolio Associates’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$247K Buy
+51,291
New +$326K ﹤0.01% 3361

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's SQZ Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in SQZ Biotechnologies Company (SQZ) in Q1 2022: 51,291 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #3361 among its holdings.

53 funds tracked by Wall St. Rank hold SQZ as of Q1 2022.

  • Parametric Portfolio Associates held 51,291 shares of SQZ Biotechnologies Company worth $247K as of Q1 2022.
  • SQZ Biotechnologies Company was a new Parametric Portfolio Associates position in Q1 2022.
  • SQZ Biotechnologies Company made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3361 holding.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.